Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revance Therapeutics (NQ: RVNC ) 4.310 +0.070 (+1.65%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Revance Therapeutics < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Investors December 15, 2021 From Law Offices of Howard G. Smith Via Business Wire RVNC SHAREHOLDERS: Robbins LLP Informs Investors of Class Action Against Revance Therapeutics, Inc. (RVNC) December 15, 2021 From Robbins LLP Via Business Wire The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Investors December 15, 2021 From The Law Offices of Frank R. Cruz Via Business Wire REVANCE THERAPEUTICS SHAREHOLDER ALERT December 14, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors December 14, 2021 From Glancy Prongay & Murray LLP Via Business Wire SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 14, 2021 From The Schall Law Firm Via Business Wire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 14, 2021 Gainers Galera Therapeutics (NASDAQ:GRTX) stock increased by 134.05% to $3.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $... Via Benzinga REVANCE THERAPEUTICS DEADLINE ALERT December 13, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire REVANCE THERAPEUTICS UPDATE December 04, 2021 Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS INVESTOR ALERT November 28, 2021 Via NewMediaWire Exposures Product Safety REVANCE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Revance Therapeutics, Inc. and Encourages Investors to Contact the Firm December 13, 2021 From Bragar Eagel & Squire, P.C. Via Business Wire ALERT: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNC December 13, 2021 From Robbins Geller Rudman & Dowd LLP Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors December 13, 2021 From Law Offices of Frank R. Cruz Via Business Wire SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 13, 2021 From The Schall Law Firm Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors December 13, 2021 From Law Offices of Howard G. Smith Via Business Wire EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RVNC December 13, 2021 From The Rosen Law Firm, P.A. Via Business Wire REVANCE THERAPEUTICS INVESTOR ALERT December 12, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS UPDATE December 11, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS SHAREHOLDER NOTICE December 09, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS SHAREHOLDER ALERT December 08, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety Lost Money in Revance Therapeutics, Inc.? December 07, 2021 From Gibbs Law Group Via Business Wire REVANCE THERAPEUTICS INVESTOR ALERT December 07, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety NASDAQ:RVNC Shareholder Alert: Investigation over Potential Wrongdoing at Revance Therapeutics, Inc. December 06, 2021 San Diego, CA -- (SBWIRE) -- 12/06/2021 -- Certain directors of Revance Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties. Via SBWire Exposures Product Safety INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm December 05, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety REVANCE THERAPEUTICS INVESTOR ALERT December 05, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS SHAREHOLDER NOTICE December 02, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS SHAREHOLDER ALERT December 01, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Exposures Product Safety REVANCE THERAPEUTICS INVESTOR ALERT November 30, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety 4 Stocks Insiders Are Buying November 30, 2021 When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... Via Benzinga REVANCE THERAPEUTICS UPDATE November 27, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
